Riskpilot← Back to searchSign inGet full accessDG VeNo Invest ApS
APSActiveCVR 38633694Filippavej 57AActivities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -18K
0% vs 2023
EBITDA margin
100.0%
0% vs 2023
Equity ratio
80.9%
Financial strength
Net profit 2024
DKK 9,1M
+64390% vs 2023
| Revenue | DKK -18K | +0% |
| EBITDA | DKK -18K | +0% |
| Net profit | DKK 9,1M | +64390% |
| Total assets | DKK 9,4M | +0% |
| Equity | DKK 7,6M | -2% |
| Employees | — | — |
Legal name
DG VeNo Invest ApS
CVR number
38633694
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
11. maj 2017
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden og en direktør i forening, af to bestyrelsesmedlemmer i forening, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er, direkte eller indirekte at investere i selskaber, samt anden virksomhed forbundet hermed efter bestyrelsens skøn.
Address
Filippavej 57A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -16 | -24 | -18 | -18 | -18 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -16 | -24 | -18 | -18 | -18 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -16 | -24 | -18 | -18 | -18 |
| Net financials | 0 | -0 | -0 | 0 | 9.060 |
| Profit before tax | -16 | -24 | -18 | -18 | 9.041 |
| Tax | -4 | -5 | -4 | -4 | -47 |
| Net profit | -13 | -19 | -14 | -14 | 9.089 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8.845 | 9.329 | 9.328 | 9.328 | 9.371 |
| Equity | 7.794 | 7.775 | 7.761 | 7.746 | 7.579 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.051 | 1.554 | 1.567 | 1.582 | 1.793 |
| Total debt | 1.051 | 1.554 | 1.567 | 1.582 | 1.793 |
EBITDA margin
-1812500.0%
This company
15.8%
Market median
-11471619% vs market
20202024
Equity ratio
80.9%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
119.9%
This company
18.4%
Market median
+552% vs market
20202024
Net profit margin
908872300.0%
This company
8.1%
Market median
+11220645579% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Management | Management | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2017 | |
| Board of Directors | 2017 | |
| Former (1) | ||
| Board of Directors | 2017 – 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CRS INTERNATIONAL ApS
DG VeNo Invest ApS Board members of DG VeNo Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Heimburger | Management | 0 companies |
| Robert John Spliid | Chairman | 0 companies |
| Mogens Saugmann | Board of Directors | 0 companies |
| Enrico Krog Iversen | Board of Directors | 0 companies |